CN103360472B - Acian Metapneumovirus antibody ELISA detection kit - Google Patents
Acian Metapneumovirus antibody ELISA detection kit Download PDFInfo
- Publication number
- CN103360472B CN103360472B CN201310325109.8A CN201310325109A CN103360472B CN 103360472 B CN103360472 B CN 103360472B CN 201310325109 A CN201310325109 A CN 201310325109A CN 103360472 B CN103360472 B CN 103360472B
- Authority
- CN
- China
- Prior art keywords
- protein
- elisa
- avian metapneumovirus
- subgroup
- sds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000002965 ELISA Methods 0.000 title claims abstract description 53
- 238000001514 detection method Methods 0.000 title claims abstract description 36
- 241000351643 Metapneumovirus Species 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 63
- 241001519465 Avian metapneumovirus Species 0.000 claims abstract description 52
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 51
- 108010068327 4-hydroxyphenylpyruvate dioxygenase Proteins 0.000 claims abstract description 47
- 239000011248 coating agent Substances 0.000 claims abstract description 34
- 238000000576 coating method Methods 0.000 claims abstract description 34
- 238000000034 method Methods 0.000 claims abstract description 25
- 239000000178 monomer Substances 0.000 claims abstract description 10
- 239000000243 solution Substances 0.000 claims description 52
- 210000002966 serum Anatomy 0.000 claims description 40
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 claims description 23
- 238000001962 electrophoresis Methods 0.000 claims description 22
- 239000013612 plasmid Substances 0.000 claims description 21
- 239000000758 substrate Substances 0.000 claims description 21
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 18
- 238000005406 washing Methods 0.000 claims description 17
- 241000287828 Gallus gallus Species 0.000 claims description 14
- 108090000790 Enzymes Proteins 0.000 claims description 13
- 102000004190 Enzymes Human genes 0.000 claims description 13
- 239000000047 product Substances 0.000 claims description 11
- 238000011084 recovery Methods 0.000 claims description 11
- 238000001976 enzyme digestion Methods 0.000 claims description 10
- 235000020183 skimmed milk Nutrition 0.000 claims description 10
- 239000003085 diluting agent Substances 0.000 claims description 9
- 239000013642 negative control Substances 0.000 claims description 9
- 238000002360 preparation method Methods 0.000 claims description 9
- 239000012089 stop solution Substances 0.000 claims description 9
- 102100029727 Enteropeptidase Human genes 0.000 claims description 8
- 108010013369 Enteropeptidase Proteins 0.000 claims description 8
- 101150034814 F gene Proteins 0.000 claims description 8
- 230000001580 bacterial effect Effects 0.000 claims description 8
- 239000007788 liquid Substances 0.000 claims description 8
- 239000013641 positive control Substances 0.000 claims description 8
- 238000003259 recombinant expression Methods 0.000 claims description 8
- 239000013598 vector Substances 0.000 claims description 8
- 238000006243 chemical reaction Methods 0.000 claims description 7
- 239000013613 expression plasmid Substances 0.000 claims description 7
- 239000000843 powder Substances 0.000 claims description 7
- 238000001262 western blot Methods 0.000 claims description 7
- 241000283707 Capra Species 0.000 claims description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 6
- 241000700605 Viruses Species 0.000 claims description 6
- 238000004458 analytical method Methods 0.000 claims description 6
- 238000005520 cutting process Methods 0.000 claims description 6
- 230000000694 effects Effects 0.000 claims description 6
- 238000011144 upstream manufacturing Methods 0.000 claims description 6
- 241000894006 Bacteria Species 0.000 claims description 5
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims description 5
- 230000029087 digestion Effects 0.000 claims description 5
- 239000012634 fragment Substances 0.000 claims description 5
- 208000015181 infectious disease Diseases 0.000 claims description 5
- 229920001213 Polysorbate 20 Polymers 0.000 claims description 4
- 238000001042 affinity chromatography Methods 0.000 claims description 4
- 239000000872 buffer Substances 0.000 claims description 4
- 239000003153 chemical reaction reagent Substances 0.000 claims description 4
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 claims description 4
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims description 4
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims description 4
- 244000144977 poultry Species 0.000 claims description 4
- 239000002244 precipitate Substances 0.000 claims description 4
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 3
- 229910052782 aluminium Inorganic materials 0.000 claims description 3
- 229940078916 carbamide peroxide Drugs 0.000 claims description 3
- 238000005119 centrifugation Methods 0.000 claims description 3
- 238000010367 cloning Methods 0.000 claims description 3
- UQLDLKMNUJERMK-UHFFFAOYSA-L di(octadecanoyloxy)lead Chemical compound [Pb+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O UQLDLKMNUJERMK-UHFFFAOYSA-L 0.000 claims description 3
- 230000006698 induction Effects 0.000 claims description 3
- 229920000136 polysorbate Polymers 0.000 claims description 3
- AQLJVWUFPCUVLO-UHFFFAOYSA-N urea hydrogen peroxide Chemical compound OO.NC(N)=O AQLJVWUFPCUVLO-UHFFFAOYSA-N 0.000 claims description 3
- 108010001336 Horseradish Peroxidase Proteins 0.000 claims description 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 2
- 239000002773 nucleotide Substances 0.000 claims description 2
- 125000003729 nucleotide group Chemical group 0.000 claims description 2
- 238000001742 protein purification Methods 0.000 claims description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 2
- 238000007447 staining method Methods 0.000 claims 2
- 210000004072 lung Anatomy 0.000 claims 1
- 239000011780 sodium chloride Substances 0.000 claims 1
- 239000000427 antigen Substances 0.000 abstract description 20
- 102000036639 antigens Human genes 0.000 abstract description 20
- 108091007433 antigens Proteins 0.000 abstract description 20
- 238000008157 ELISA kit Methods 0.000 abstract description 7
- 201000010099 disease Diseases 0.000 abstract description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 7
- 230000002265 prevention Effects 0.000 abstract description 3
- 206010066226 Metapneumovirus infection Diseases 0.000 abstract description 2
- 238000011160 research Methods 0.000 abstract description 2
- 238000013399 early diagnosis Methods 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
- 230000000903 blocking effect Effects 0.000 description 13
- 238000010790 dilution Methods 0.000 description 12
- 239000012895 dilution Substances 0.000 description 12
- 235000013330 chicken meat Nutrition 0.000 description 11
- 238000011161 development Methods 0.000 description 9
- 102000037865 fusion proteins Human genes 0.000 description 9
- 108020001507 fusion proteins Proteins 0.000 description 9
- 239000000499 gel Substances 0.000 description 7
- 230000035945 sensitivity Effects 0.000 description 7
- 238000010586 diagram Methods 0.000 description 6
- 239000012153 distilled water Substances 0.000 description 6
- 238000000746 purification Methods 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 5
- 239000006166 lysate Substances 0.000 description 5
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 4
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 4
- 206010051497 Rhinotracheitis Diseases 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 4
- 238000003556 assay Methods 0.000 description 4
- 239000012154 double-distilled water Substances 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 230000005847 immunogenicity Effects 0.000 description 3
- 235000013594 poultry meat Nutrition 0.000 description 3
- 238000012163 sequencing technique Methods 0.000 description 3
- 238000010186 staining Methods 0.000 description 3
- 241000271566 Aves Species 0.000 description 2
- 230000004544 DNA amplification Effects 0.000 description 2
- 241000711955 Turkey rhinotracheitis virus Species 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000003472 neutralizing effect Effects 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 239000012224 working solution Substances 0.000 description 2
- 241000272525 Anas platyrhynchos Species 0.000 description 1
- 241000272517 Anseriformes Species 0.000 description 1
- 235000011330 Armoracia rusticana Nutrition 0.000 description 1
- 240000003291 Armoracia rusticana Species 0.000 description 1
- 101100298998 Caenorhabditis elegans pbs-3 gene Proteins 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 238000009007 Diagnostic Kit Methods 0.000 description 1
- 108010042407 Endonucleases Proteins 0.000 description 1
- 102000004533 Endonucleases Human genes 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 241000711504 Paramyxoviridae Species 0.000 description 1
- 241000286209 Phasianidae Species 0.000 description 1
- 241000711904 Pneumoviridae Species 0.000 description 1
- 241000711902 Pneumovirus Species 0.000 description 1
- 208000027954 Poultry disease Diseases 0.000 description 1
- 208000036071 Rhinorrhea Diseases 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- 101710172711 Structural protein Proteins 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 108010087302 Viral Structural Proteins Proteins 0.000 description 1
- 230000010530 Virus Neutralization Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000009313 farming Methods 0.000 description 1
- 244000144992 flock Species 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 230000000951 immunodiffusion Effects 0.000 description 1
- 238000010166 immunofluorescence Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 238000012257 pre-denaturation Methods 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000000601 reactogenic effect Effects 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 239000012898 sample dilution Substances 0.000 description 1
- 206010041232 sneezing Diseases 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
Landscapes
- Peptides Or Proteins (AREA)
Abstract
本发明提供了一种禽偏肺病毒抗体ELISA检测试剂盒,该试剂盒是基于A亚群禽偏肺病毒F蛋白的单体蛋白为包被抗原建立的检测禽偏肺病毒抗体的ELISA试剂盒。本发明还提供了用于制备上述试剂盒的包被抗原即F蛋白的单体蛋白的制备方法,通过本发明提供的方法制备的F蛋白具有良好的反应原性,且本发明所建立的ELISA检测试剂盒为禽偏肺病毒感染的早期诊断和检测提供了有效的方法,为该疾病的预防研究起到了显著促进作用。The invention provides an ELISA detection kit for avian metapneumovirus antibody, which is an ELISA kit for detecting avian metapneumovirus antibody based on the monomer protein of A subgroup avian metapneumovirus F protein as a coating antigen. The present invention also provides a method for preparing the monomeric protein of F protein, which is the coating antigen of the above kit, the F protein prepared by the method provided by the present invention has good reactogenicity, and the ELISA established by the present invention The detection kit provides an effective method for the early diagnosis and detection of avian metapneumovirus infection, and has played a significant role in promoting the prevention research of the disease.
Description
技术领域technical field
本发明涉及免疫学技术领域,具体涉及一种A亚群禽偏肺病毒F蛋白的单体蛋白以及用于检测上述A亚群禽偏肺病毒抗体的ELISA试剂盒。The invention relates to the technical field of immunology, in particular to a monomeric protein of F protein of subgroup A avian metapneumovirus and an ELISA kit for detecting the antibody of subgroup A avian metapneumovirus.
背景技术Background technique
禽偏肺病毒(Avian Metapneumovirus,aMPV),又名火鸡鼻气管炎病毒(Turkey Rhinotracheitis Virus,TRTV),属于副粘病毒科肺病毒亚科肺病毒属,是一种世界范围内分布的禽类重要病原。此病毒主要引起火鸡和鸡的上呼吸道系统疾病,如火鸡鼻气管炎(Turkey Rhinotracheitis,TRT)、禽鼻气管炎(AvianRhinotracheitis,ART),并且与肉鸡肿头综合征(Swollen Head Syndrome,SHS)关系密切。其中,火鸡鼻气管炎是危害火鸡养殖业的一种急性高度接触性传染病,该病以流鼻涕、打喷嚏、眶下窦肿胀、头部肿胀和产蛋率下降等症状为主要特征,传染率、发病率可高达100%,死亡率随饲养管理和卫生条件而变化,若有混合感染,死亡率可高达25%~40%。该病传染性强,传播迅速,能引起多种禽类感染发病并造成严重的经济损失。目前我国是世界上排名第一的养鸡大国,鸡的饲养量96亿只,每年因各类禽病带来的死亡率高达20%~25%,损失几百亿人民币。Avian Metapneumovirus (aMPV), also known as Turkey Rhinotracheitis Virus (TRTV), belongs to the Pneumovirus genus of the Paramyxoviridae Pneumoviridae subfamily, and is an important species of poultry distributed worldwide. pathogen. This virus mainly causes upper respiratory diseases of turkeys and chickens, such as turkey rhinotracheitis (TRT), avian rhinotracheitis (Avian Rhinotracheitis, ART), and is associated with broiler chicken swollen head syndrome (Swollen Head Syndrome, SHS) ) are closely related. Among them, turkey rhinotracheitis is an acute and highly contagious infectious disease that endangers the turkey farming industry. The main symptoms of the disease are runny nose, sneezing, swelling of the infraorbital sinus, swelling of the head, and decreased egg production rate. , The infection rate and morbidity rate can be as high as 100%, and the mortality rate varies with feeding management and sanitary conditions. If there is mixed infection, the mortality rate can be as high as 25% to 40%. The disease is highly contagious and spreads rapidly, which can cause a variety of poultry infections and cause severe economic losses. At present, my country is the largest chicken-raising country in the world, with 9.6 billion chickens. The mortality rate due to various poultry diseases is as high as 20% to 25% every year, and tens of billions of yuan are lost.
目前,血清学是aMPV诊断最常用的方法,特别是未接种疫苗鸡群。常用的方法有间接酶联免疫吸附实验、病毒中和反应、间接免疫荧光和免疫扩散。其中,ELISA是最常用的方法,具有快速、灵敏、血清用量少、易操作的特点。市场上商品化aMPV ELISA检测试剂盒是来自欧洲和美国,主要用于血清抗体的检测,其包被的抗原是病毒接种细胞后提取的全病毒,常常给该病的传播带来潜在的危害;此外,这些检测试剂对特定亚群比如A亚群的抗体检测的敏感度不够;特别是目前仍没有使用表达的重组蛋白做包被抗原进行ELISA检测试剂盒的研制。aMPV含有多种病毒结构蛋白,其中F蛋白是病毒的主要结构蛋白,含有能保护机体抵抗aMPV感染的中和性抗原表位,但该F蛋白含有多个跨膜区影响该蛋白在表达系统中的重组表达。如何表达含有中和性抗原表位的重组蛋白作为包被抗原建立ELISA方法开发抗体检测试剂盒用于该病的检测具有现实意义。目前禽偏肺病毒感染在我国多种家禽品种的养殖场发生与流行,因此,研制特异、灵敏、简便的诊断试剂盒是我国当前防控该病的迫切需求。Currently, serology is the most commonly used method for aMPV diagnosis, especially in unvaccinated flocks. Commonly used methods are indirect enzyme-linked immunosorbent assay, virus neutralization reaction, indirect immunofluorescence and immunodiffusion. Among them, ELISA is the most commonly used method, which has the characteristics of rapidity, sensitivity, less serum consumption and easy operation. The commercial aMPV ELISA detection kits on the market are from Europe and the United States, and are mainly used for the detection of serum antibodies. The antigen coated is the whole virus extracted after the virus is inoculated into cells, which often brings potential harm to the spread of the disease; In addition, these detection reagents are not sensitive enough to detect antibodies of specific subgroups such as subgroup A; especially, there is still no development of ELISA detection kits using expressed recombinant proteins as coating antigens. aMPV contains a variety of viral structural proteins, among which F protein is the main structural protein of the virus, which contains neutralizing epitopes that can protect the body against aMPV infection, but the F protein contains multiple transmembrane regions that affect the expression of the protein in the system recombinant expression. How to express the recombinant protein containing neutralizing antigenic epitope as the coating antigen and establish the ELISA method to develop the antibody detection kit for the detection of the disease has practical significance. At present, avian metapneumovirus infection occurs and is prevalent in various poultry farms in my country. Therefore, the development of specific, sensitive and simple diagnostic kits is an urgent need for the prevention and control of this disease in my country.
发明内容Contents of the invention
为了克服现有技术的缺陷,本发明的一个目的是制备用于检测禽偏肺病毒抗体的ELISA试剂盒,该试剂盒为禽偏肺病毒抗体的检测提供了一套有效的工具。In order to overcome the defects of the prior art, an object of the present invention is to prepare an ELISA kit for detecting the avian metapneumovirus antibody, which provides a set of effective tools for the detection of the avian metapneumovirus antibody.
本发明的另一个目的是提供一种A亚型禽偏肺病毒F蛋白的单体蛋白的制备与纯化方法,为禽偏肺病毒抗体检测试剂盒提供包被抗原。Another object of the present invention is to provide a method for preparing and purifying monomeric protein of A-subtype avian metapneumovirus F protein, so as to provide coating antigen for the avian metapneumovirus antibody detection kit.
本发明的再一个目的是上述ELISA试剂盒在快速检测禽偏肺病毒上的应用。Another object of the present invention is the application of the above ELISA kit in rapid detection of avian metapneumovirus.
为实现以上目的,本发明首先提供了一种A亚型禽偏肺病毒F蛋白,该蛋白是在将A亚型禽偏肺病毒F蛋白野生型的基础上,去除其部分跨膜区得到,其氨基酸序列如SEQ ID No.2所示。本发明还包括编码序列的基因,其核苷酸序列如SEQ ID No.1所示。研究发现,该蛋白具有良好的免疫反应原性,可用于aMPV的抗体检测。To achieve the above object, the present invention firstly provides a kind of A subtype avian metapneumovirus F protein, which is obtained by removing part of the transmembrane region of the A subtype avian metapneumovirus F protein wild type, Its amino acid sequence is shown in SEQ ID No.2. The present invention also includes the gene of coding sequence, its nucleotide sequence is as shown in SEQ ID No.1. The study found that the protein has good immunogenicity and can be used for antibody detection of aMPV.
据此,本发明提供一种禽偏肺病毒抗体ELISA检测试剂盒,其包括A型禽偏肺病毒F蛋白的单体蛋白包被的ELISA板。Accordingly, the present invention provides an ELISA detection kit for avian metapneumovirus antibody, which comprises an ELISA plate coated with a type A avian metapneumovirus F protein monomer protein.
上述的检测禽偏肺病毒的ELISA试剂盒还包括酶标二抗,阳性对照,阴性对照,洗涤液,样品稀释液,底物液A,底物液B和终止液。The above ELISA kit for detecting avian metapneumovirus also includes an enzyme-labeled secondary antibody, a positive control, a negative control, a washing solution, a sample diluent, a substrate solution A, a substrate solution B and a stop solution.
其中,所述酶标二抗为辣根过氧化物标记羊抗鸡单克隆抗体;所述阳性对照为自然感染A亚群禽肺病毒的鸡血清;所述阴性对照为正常鸡血清;所述的包被液,洗涤液,封闭液,样品稀释液,底物液A,底物液B和终止液的组分及配比如下:Wherein, the enzyme-labeled secondary antibody is horseradish peroxide-labeled goat anti-chicken monoclonal antibody; the positive control is chicken serum naturally infected with subgroup A avian pneumovirus; the negative control is normal chicken serum; The components and proportions of coating solution, washing solution, blocking solution, sample diluent, substrate solution A, substrate solution B and stop solution are as follows:
包被液:无水Na2CO31.59g,NaHCO32.93g,加蒸馏水至1000mL;Coating solution: anhydrous Na 2 CO 3 1.59g, NaHCO 3 2.93g, add distilled water to 1000mL;
洗涤液:NaCl8.0g,KH2PO40.2g,Na2HPO4·12H2O2.9g,KCl0.2g,Tween-200.5mL,加双蒸水至1000mL;Washing liquid: NaCl8.0g, KH 2 PO 4 0.2g, Na 2 HPO 4 12H 2 O2.9g, KCl0.2g, Tween-200.5mL, add double distilled water to 1000mL;
封闭液:5%脱脂奶粉;Blocking solution: 5% skimmed milk powder;
样品稀释液:含5%脱脂奶粉的洗涤液;Sample diluent: washing solution containing 5% skimmed milk powder;
底物液A:过氧化脲1.0g,Na2HPO4·12H2O35.8g,柠檬酸·H2O10.3g,Tween-20100μL,加1000mL蒸馏水;Substrate solution A: carbamide peroxide 1.0g, Na 2 HPO 4 12H 2 O 35.8g, citric acid H 2 O 10.3g, Tween-20 100μL, add 1000mL distilled water;
底物液B:TMB700mg,DMSO40mL,充分溶解,然后加蒸馏水960mL,柠檬酸·H2O10.3g;Substrate solution B: TMB700mg, DMSO40mL, fully dissolved, then add distilled water 960mL, citric acid· H2O10.3g ;
终止液:2mol/L硫酸溶液。Stop solution: 2mol/L sulfuric acid solution.
上述用于ELISA试剂盒作为酶标板包被抗原的A型禽偏肺病毒F蛋白的单体蛋白制备,包括以下步骤:人工合成A亚群禽偏肺病毒F蛋白基因序列为模板扩增得到SEQ ID No.1所示的序列,将上述目的基因导入到pBCX载体中,连接后的产物转化DH5α感受态细胞,提取质粒双酶切后鉴定筛选出阳性重组表达质粒pBCX-aMPV-A-F,将上述阳性重组表达质粒转化BL21感受态细胞后诱导表达,SDS-PAGE电泳分析表达蛋白,再采用Ni柱亲和层析方法,对目的蛋白进行纯化,然后分别用SDS-PAGE和Western blot检测蛋白纯化结果,纯化后的目的蛋白用肠激酶处理,处理后用SDS-PAGE检验酶切结果,电泳结束后用KCl染色法切胶回收,将回收所得的F蛋白经SDS-PAGE电泳进行回收效果鉴定,ELISA分析切胶回收蛋白的抗原性。The above-mentioned monomeric protein preparation of the A-type avian metapneumovirus F protein used in the ELISA kit as the coating antigen of the enzyme plate comprises the following steps: artificially synthesizing the A subgroup avian metapneumovirus F protein gene sequence as a template to amplify The sequence shown in SEQ ID No.1, the above-mentioned target gene was introduced into the pBCX vector, the product after ligation was transformed into DH5α competent cells, the plasmid was extracted and double-digested, and the positive recombinant expression plasmid pBCX-aMPV-A-F was identified and screened. The above positive recombinant expression plasmids were transformed into BL21 competent cells to induce expression, analyzed the expressed protein by SDS-PAGE electrophoresis, and then purified the target protein by Ni column affinity chromatography, and then detected the protein purification by SDS-PAGE and Western blot respectively As a result, the purified target protein was treated with enterokinase, and after the treatment, the digestion result was checked by SDS-PAGE. After electrophoresis, the gel was cut and recovered by KCl staining, and the recovery effect of the recovered F protein was identified by SDS-PAGE electrophoresis. The antigenicity of the recovered protein was analyzed by ELISA.
具体地,A型禽偏肺病毒F蛋白的单体蛋白制备,可以包括以下步骤:Specifically, the monomeric protein preparation of type A avian metapneumovirus F protein may comprise the following steps:
1)扩增目的基因。以人工合成A亚群禽偏肺病毒F蛋白基因序列为模板,通过PCR方法对其F基因进行扩增、克隆得到目的基因(F基因,其缺失部分跨膜区),上游引物加上Kpn Ⅰ酶切位点,下游引物加Hind Ⅲ酶切位点,引物见表1:1) Amplify the target gene. Using artificially synthesized subgroup A avian metapneumovirus F protein gene sequence as a template, its F gene was amplified and cloned by PCR to obtain the target gene (F gene, which lacked part of the transmembrane region), and the upstream primer plus Kpn Ⅰ Restriction sites, downstream primers plus Hind III restriction sites, primers are listed in Table 1:
表1F基因的扩增引物Table 1F Gene Amplification Primers
2)F基因回收以及PBCX质粒提取后用Kpn Ⅰ、Hind Ⅲ进行双酶切,回收目的片段,在T4DNA连接酶作用下将目的基因和载体按摩尔比5:1在16°C下连接12-16h,转化感受态细胞DH5α,提取质粒,经Kpn Ⅰ和Hind Ⅲ双酶切鉴定正确后获得阳性重组表达质粒pBCX-aMPV-A-F。2) After the recovery of the F gene and the extraction of the PBCX plasmid, perform double enzyme digestion with Kpn Ⅰ and Hind Ⅲ to recover the target fragment, and under the action of T4 DNA ligase, the target gene and the vector were ligated at a molar ratio of 5:1 at 16°C for 12- At 16 hours, the competent cell DH5α was transformed, and the plasmid was extracted, and the positive recombinant expression plasmid pBCX-aMPV-A-F was obtained after Kpn Ⅰ and Hind Ⅲ double enzyme digestion and identification.
3)然后取质粒pBCX-aMPV-A-F转化BL21感受态细胞,获得的阳性质粒菌于37°C培养,待A600值达到0.4~0.6时,加入IPTG至终浓度为1.2mmol/L进行诱导表达,收集诱导表达后4h的菌体,超声波破碎,离心后取沉淀进行SDS-PAGE电泳分析。3) Then take the plasmid pBCX-aMPV-A-F to transform BL21 competent cells, and culture the obtained positive plasmid bacteria at 37°C. When the A600 value reaches 0.4-0.6, add IPTG to a final concentration of 1.2mmol/L to induce expression. The bacterial cells 4 hours after the induced expression were collected, ultrasonically disrupted, and the precipitate was collected after centrifugation for SDS-PAGE electrophoresis analysis.
4)然后采用Ni柱亲和层析方法,纯化目的蛋白,纯化后的目的蛋白进行SDS-PAGE和Western blot鉴定,经鉴定的F蛋白用肠激酶进行处理,然后进行SDS-PAGE电泳,电泳结束后取下凝胶,先用双蒸水洗涤,然后浸入4°C预冷的250mmol/L的KCl溶液中显色5min,将染成银白色的目的蛋白条带切下,PBS洗涤3次,将胶条移入一干净的小袋中碾碎,将碎末刮入EP管中,加入PBS震荡混匀反复冻融3次,12000r/min离心2min,吸取上清,SDS-PAGE电泳进行回收效果鉴定。4) Then use Ni column affinity chromatography to purify the target protein. The purified target protein is identified by SDS-PAGE and Western blot. The identified F protein is treated with enterokinase, and then SDS-PAGE electrophoresis is performed, and the electrophoresis ends Finally, the gel was removed, washed with double distilled water, and then immersed in 4°C pre-cooled 250mmol/L KCl solution for 5min to develop color, and the band of the target protein stained silvery white was cut off, washed 3 times with PBS, Move the strip into a clean pouch and crush it, scrape the powder into an EP tube, add PBS to shake and mix, freeze and thaw 3 times, centrifuge at 12000r/min for 2min, absorb the supernatant, and identify the recovery effect by SDS-PAGE electrophoresis .
5)ELISA分析切胶回收蛋白的抗原性。5) ELISA was used to analyze the antigenicity of the protein recovered from gel cutting.
本发明还提供了上述试剂盒的制备方法,包括A亚群禽偏肺病毒F蛋白的ELISA板的制备,其方法为:用碳酸盐(pH9.6,浓度0.5mol/L)缓冲液作包被液,用上述包被液将F蛋白单体稀释为10μg/mL,按100μL/孔加入ELISA反应板中,37°C封闭1小时,4°C包被过夜,拍干,再用5%脱脂奶37°C封闭2小时,以含0.05%吐温的PBST洗涤,拍干用铝膜真空封闭保存、备用。The present invention also provides the preparation method of the above kit, including the preparation of the ELISA plate of A subgroup avian metapneumovirus F protein. The method is: use carbonate (pH9.6, concentration 0.5mol/L) buffer solution as Coating solution, use the above coating solution to dilute the F protein monomer to 10 μg/mL, add 100 μL/well into the ELISA reaction plate, block at 37°C for 1 hour, coat at 4°C overnight, pat dry, and then use 5 % skimmed milk was sealed at 37°C for 2 hours, washed with PBST containing 0.05% Tween, patted dry, sealed with aluminum film and stored in vacuum, and used for later use.
基于本发明试剂盒,可采用以下ELISA方法,检测A亚群禽偏肺病毒抗体:Based on the kit of the present invention, the following ELISA method can be used to detect the A subgroup avian metapneumovirus antibody:
1)加样:向酶标板微孔中加入用样品稀释液1:100倍稀释后的待检测血清样品100μL,37°C恒温孵育30min;1) Adding samples: Add 100 μL of the serum sample to be tested diluted 1:100 times with the sample diluent to the microwell of the microplate, and incubate at 37°C for 30 minutes;
2)洗涤:倒出孔中的液体,每孔中加入洗涤液250μL,洗涤3次并拍干;2) Washing: Pour out the liquid in the wells, add 250 μL of washing solution to each well, wash 3 times and pat dry;
3)加酶标抗体:每孔中加入酶标抗体工作液100μL,37°C恒温孵育30min;3) Add enzyme-labeled antibody: add 100 μL of enzyme-labeled antibody working solution to each well, and incubate at 37°C for 30 minutes;
4)洗涤:倒出孔中的液体,每孔中加入洗涤液250μL,洗涤3次并拍干;4) Washing: Pour out the liquid in the wells, add 250 μL of washing solution to each well, wash 3 times and pat dry;
5)加底物液:每孔中先加入底物液A50μL,再加入底物液B50μL,避光显色15~20min;5) Add substrate solution: first add 50 μL of substrate solution A to each well, then add 50 μL of substrate solution B, and develop color in the dark for 15-20 minutes;
6)加终止液:每孔中加入终止液50μL;6) Add stop solution: add 50 μL of stop solution to each well;
7)测定:用酶标仪在450nm处测定每孔的吸光光度值(OD450值)。7) Determination: Measure the absorbance value (OD450 value) of each well at 450nm with a microplate reader.
本发明提供了使用可溶性pBCX载体,表达了A亚群禽偏肺病毒缺失部分跨膜区的F蛋白,并利用pBCX载体的6×His标签,对表达的融合蛋白进行纯化,Western-blot检测证明纯化的蛋白具有反应原性,后用肠激酶对纯化的蛋白进行切割,获得去掉载体标签的单体蛋白,得到了免疫原性较高的蛋白。本发明提供的此蛋白构建体系,解决了F蛋白单体纯化困难的问题。The present invention provides the use of soluble pBCX vectors to express the F protein of the transmembrane region missing from subgroup A avian metapneumovirus, and use the 6×His tag of the pBCX vector to purify the expressed fusion protein, which is proved by Western-blot detection The purified protein has reactogenicity, and then the purified protein is cut with enterokinase to obtain a monomeric protein with the carrier tag removed, and a protein with higher immunogenicity is obtained. The protein construction system provided by the present invention solves the problem of difficult purification of F protein monomers.
本发明以基因工程表达的F蛋白为基础制备而成,F蛋白单体为非全病毒抗原,安全性好,不含无关杂蛋白,且具有良好抗原性,因此所发明的检测试剂盒具有很高的特异性和敏感性。The present invention is prepared on the basis of the F protein expressed by genetic engineering. The F protein monomer is a non-whole virus antigen, which has good safety, does not contain irrelevant miscellaneous proteins, and has good antigenicity. Therefore, the invented detection kit has great High specificity and sensitivity.
本发明构建的用于A亚群禽偏肺病毒检测的试剂盒,操作简便易行,检测快速敏感,特别适用于临床上对禽偏肺病毒抗体的快速检测,为该疾病的预防研究起到了显著促进作用。The kit for the detection of subgroup A avian metapneumovirus constructed by the present invention is simple and easy to operate, fast and sensitive in detection, and is especially suitable for the rapid detection of antibodies to avian metapneumovirus clinically, and has played a role in the prevention and research of this disease. significant promotion.
附图说明Description of drawings
图1是F基因扩增的电泳图,其中1:F蛋白的目的条带,2:空白对照,M:MarkerDL2000。Figure 1 is the electropherogram of F gene amplification, in which 1: the target band of F protein, 2: blank control, M: MarkerDL2000.
图2是F基因克隆到pBCX载体得到的重组质粒PCR鉴定图,其中M:DNAMarkerDL2000,1~10:重组质粒PCR扩增片段。Fig. 2 is the PCR identification diagram of the recombinant plasmid obtained by cloning the F gene into the pBCX vector, wherein M: DNAMarkerDL2000, 1-10: PCR amplified fragments of the recombinant plasmid.
图3是F基因克隆到pBCX载体得到的重组质粒pBCX-F的酶切鉴定图,其中M:DNAMarkerDL2000,1~3:阳性重组质粒pBCX-F的酶切片段。Fig. 3 is the enzyme digestion identification diagram of the recombinant plasmid pBCX-F obtained by cloning the F gene into the pBCX vector, wherein M: DNAMarkerDL2000, 1-3: restriction enzyme fragments of the positive recombinant plasmid pBCX-F.
图4是pBCX-aMPV-A-F转化到BL21感受态细胞后,提取质粒PCR鉴定图,其中M:DNAMarkerDL2000,1:重组质粒的PCR产物,3:空白对照。Figure 4 is a PCR identification map of the extracted plasmid after pBCX-aMPV-A-F was transformed into BL21 competent cells, where M: DNAMarkerDL2000, 1: PCR product of recombinant plasmid, 3: blank control.
图5是诱导表达蛋白的SDS-PAGE分析图,其中M:175Marker,1:空质粒表达产物,2~8分别为1.2mmol/LIPTG诱导0~6h的细菌裂解产物。Fig. 5 is the SDS-PAGE analysis diagram of the induced expression protein, wherein M: 175 Marker, 1: empty plasmid expression product, 2-8 are bacterial lysates induced by 1.2mmol/LIPTG for 0-6h respectively.
图6是融合蛋白的可溶性分析鉴定图,其中M:175Marker,1:细菌裂解总产物,2:细菌裂解沉淀;3:细菌裂解上清。Figure 6 is a diagram of the soluble analysis and identification of the fusion protein, where M: 175Marker, 1: total bacterial lysate product, 2: bacterial lysate precipitate; 3: bacterial lysate supernatant.
图7是纯化蛋白的SDS-PAGE分析图,其中M:175Marker,1~4:纯化洗脱后的第1至4管产物。Figure 7 is the SDS-PAGE analysis diagram of the purified protein, where M: 175 Marker, 1-4: the 1st to 4th tube products after purification and elution.
图8是纯化蛋白的Western-blot分析图,(a)中M:175Marker,1:为纯化的融合蛋白产物;(b)中M:175Marker,1、2、3:为为纯化的融合蛋白产物。Figure 8 is the Western-blot analysis diagram of the purified protein, (a) M: 175Marker, 1: the purified fusion protein product; (b) M: 175Marker, 1, 2, 3: the purified fusion protein product .
图9是酶切后KCl染色切胶回收目标蛋白的鉴定结果,其中M:175Marker,1、2:分别为酶切回收后的两管产物。Figure 9 is the identification result of the target protein recovered by KCl staining and gel cutting after enzyme digestion, where M: 175Marker, 1, 2: are the two tube products after enzyme digestion and recovery.
具体实施方式Detailed ways
以下实施例用于对本发明的进一步说明,但不应该理解为对本发明的限制。在不背离本发明精神和实质的前提下,对本发明所做的修饰或者替换,均属于本发明的范畴。The following examples are used to further illustrate the present invention, but should not be construed as limiting the present invention. On the premise of not departing from the spirit and essence of the present invention, all modifications or replacements made to the present invention belong to the scope of the present invention.
实施例1A亚群禽偏肺病毒F蛋白的蛋白单体的制备及纯化Preparation and purification of the protein monomer of embodiment 1A subgroup avian metapneumovirus F protein
人工合成SEQ ID NO.1所示的A亚群禽偏肺病毒F蛋白的基因序列,用Oligo6.0软件设计一对特异性引物,上游引物加上KpnⅠ酶切位点,下游引物加HindⅢ酶切位点,上游引物是:5’-GGGGTACCGAGGCAGTATCCACATTAGGG-3’,下游引物是:5’-CCCAAGCTTCTTGGCATCTGCACCTAG-3’。以pcmy-myc-L质粒(购于Invitrogen公司)为模板在20μL反应体系中进行扩增(ddH2O11.5μL、5×Buffer4μL、Taq酶0.2μL、dNTP2μL、上游引物1μL、下游引物1μL、DNA模板0.3μL).扩增条件为:94°C预变性3min;94°C变性30s,59°C退火45s,72°C延伸1.5min,共35个循环;72°C延伸10min;4°C保存(扩增结果见图1)。Artificially synthesize the gene sequence of F protein of subgroup A avian metapneumovirus shown in SEQ ID NO.1, design a pair of specific primers with Oligo6.0 software, add KpnⅠ restriction site to the upstream primer, and add HindⅢ enzyme to the downstream primer Cutting site, the upstream primer is: 5'-GG GGTACC GAGGCAGTATCCACATTAGGG-3', the downstream primer is: 5'-CCC AAGCTT CTTGGCATCTGCACCTAG-3'. Using the pcmy-myc-L plasmid (purchased from Invitrogen) as a template, amplify in a 20 μL reaction system (ddH 2 O 11.5 μL, 5×Buffer 4 μL, Taq enzyme 0.2 μL, dNTP 2 μL, upstream primer 1 μL, downstream primer 1 μL, DNA Template 0.3 μL). The amplification conditions are: 94°C pre-denaturation for 3 minutes; 94°C denaturation for 30 seconds, 59°C annealing for 45 seconds, 72°C extension for 1.5 minutes, a total of 35 cycles; 72°C extension for 10 minutes; 4°C Save (see Figure 1 for the amplification results).
取100μL PCR产物进行琼脂糖凝胶电泳,100V电泳35~40min,紫外检测产物分析结果,并进行切胶回收。目的片段经Kpn Ⅰ和Hind Ⅲ双酶切后与经Kpn Ⅰ和Hind Ⅲ双酶切后的质粒按摩尔比5:1在16°C下连接12~16h,转化DH5α,37°C培养过夜。挑选菌落提取质粒,使用特异性引物进行PCR扩增,用上述内切酶消化,电泳鉴定(结果见图2)。鉴定正确后的阳性菌落经质粒测序进行进一步验证,并确认其基因序列正确,将测序正确的重组表达质粒命名为pBCX-aMPV-A-F(结果见图3)。Take 100 μL of PCR products for agarose gel electrophoresis, 100V electrophoresis for 35 to 40 minutes, detect the product analysis results with ultraviolet light, and perform gel cutting and recovery. After double digestion with Kpn Ⅰ and Hind Ⅲ, the target fragment was ligated with the plasmid after double digestion with Kpn Ⅰ and Hind Ⅲ at a molar ratio of 5:1 at 16°C for 12-16 hours, transformed into DH5α, and cultured at 37°C overnight. Select colonies to extract plasmids, use specific primers for PCR amplification, digest with the above-mentioned endonucleases, and identify by electrophoresis (results shown in Figure 2). The correctly identified positive colonies were further verified by plasmid sequencing, and their gene sequences were confirmed to be correct, and the recombinant expression plasmids with correct sequencing were named pBCX-aMPV-A-F (results shown in Figure 3).
从测序正确的菌落中提取质粒转化BL21感受态细胞,获得重组菌(结果见图4),于LB液体培养基中培养重组菌,待菌液在600nm光密度(optical density,OD)下的值达到0.4~0.6时,加入异丙基-β-D-硫代半乳糖苷(IPTG)使其终浓度为1.2mmol/L,诱导表达。收集不同诱导时间表达的菌体,超声波破碎,离心后分别取上清和沉淀进行SDS-PAGE电泳,结果表明诱导4h后表达达最大量(结果见图5)和融合的目的蛋白绝大部分是以可溶形式表达的(结果见图6)。Extract plasmids from colonies with correct sequencing to transform BL21 competent cells to obtain recombinant bacteria (results shown in Figure 4), culture recombinant bacteria in LB liquid medium, and wait for the value of the bacterial solution at 600nm optical density (OD) When it reaches 0.4-0.6, add isopropyl-β-D-thiogalactoside (IPTG) to make the final concentration 1.2mmol/L to induce expression. The bacteria expressed at different induction times were collected, ultrasonically disrupted, and after centrifugation, the supernatant and precipitate were taken for SDS-PAGE electrophoresis. The results showed that the expression reached the maximum after 4 hours of induction (results shown in Figure 5) and most of the fused target protein was derived from expressed in soluble form (results shown in Figure 6).
融合蛋白确定为分泌型表达后,直接将融合蛋白细菌裂解液用Ni-NTA纯化柱对目的蛋白进行纯化,用洗脱液洗脱纯化柱,收集洗脱液,洗脱液中含有目的融合蛋白,去掉部分跨膜区的F蛋白加上载体上的标签蛋白,融合后的蛋白大小为74kDa,用紫外分光光度计测定洗脱液中蛋白的浓度,最高一支为27mg/mL(结果见图7)。After the fusion protein is confirmed to be secreted expression, the bacterial lysate of the fusion protein is directly purified with a Ni-NTA purification column to purify the target protein, and the purification column is eluted with an eluent, and the eluate is collected, which contains the target fusion protein , removing part of the F protein in the transmembrane region plus the tagged protein on the carrier, the size of the fused protein is 74kDa, and the concentration of the protein in the eluate is measured with a UV spectrophotometer, the highest one is 27mg/mL (results shown in Fig. 7).
经SDS-PAGE电泳,利用Western-blot对纯化的融合蛋白进行反应原性分析,一抗为A亚型aMPV F蛋白的单抗,二抗为HRP标记的山羊抗小鼠IgG,检测结果显示:在74kDa处有一条较深的目的条带,这说明重组的融合蛋白具有反应原性,且目的条带的大小与SDS-PAGE表达的蛋白大小位置一致、条带单一,将纯化后蛋白的WB检测结果与纯化前蛋白的WB检测结果进行比较,可以证明融合蛋白纯化成功(结果见图8)。After SDS-PAGE electrophoresis, Western-blot was used to analyze the reactogenicity of the purified fusion protein. The primary antibody was a monoclonal antibody to subtype A aMPV F protein, and the secondary antibody was HRP-labeled goat anti-mouse IgG. The test results showed: There is a darker target band at 74kDa, which indicates that the recombinant fusion protein is reactogenic, and the size of the target band is consistent with the size and position of the protein expressed by SDS-PAGE, and the band is single. WB of the purified protein Comparing the detection results with the WB detection results of the protein before purification can prove that the fusion protein was successfully purified (results shown in Figure 8).
F蛋白用肠激酶进行处理,然后进行SDS-PAGE电泳,电泳结束后取下凝胶,先用双蒸水洗涤,然后浸入4°C预冷的250mmol/L的KCL溶液中显色5min,将染成银白色的目的蛋白条带切下,PBS洗涤3次,将胶条移入一干净的小袋中碾碎,将碎末刮入EP管中,加入PBS震荡混匀反复冻融3次,12000r/min离心2min,吸取上清,SDS-PAGE电泳进行回收效果鉴定(结果见图9)。The F protein was treated with enterokinase, and then SDS-PAGE electrophoresis was performed. After the electrophoresis, the gel was removed, washed with double distilled water, and then immersed in 4°C pre-cooled 250mmol/L KCL solution for 5min to develop color. Cut off the band of the target protein stained silvery white, wash with PBS 3 times, transfer the strip into a clean pouch and grind it, scrape the minced powder into an EP tube, add PBS to shake and mix, freeze and thaw 3 times repeatedly, 12000r Centrifuge for 2 min at 1/min, draw the supernatant, and conduct SDS-PAGE electrophoresis to identify the recovery effect (results shown in Figure 9).
实施例2本发明构建的F蛋白单体的免疫原性鉴定Example 2 Identification of the immunogenicity of the F protein monomer constructed by the present invention
将酶切回收的F蛋白和未经酶切的F蛋白用pH9.6的0.5mol/L碳酸盐缓冲液稀释到10μg/mL包被96孔板,以禽偏肺病毒感染鸡阳性血清和阴性血清为一抗依次做3个梯度稀释,分别为1:100、1:300、1:500。以HRP标记的山羊抗鸡IgG为二抗,工作浓度为1:10000;每个样品平行做2孔,经TMB显色后,读取各孔OD450nm值,结果显示:不经肠激酶酶切且带有载体标签的蛋白作为ELISA板包被抗原,检测血清时,阴性血清的OD值在0.6-0.8之间,已经接近阳性血清的OD值;而经过肠激酶酶切处理后只保留单体蛋白作为ELISA板的包被抗原,检测血清时,阴性OD值在0.1-0.2之间,阳性OD值与阴性OD值的P/N值在3.6-4.45之间,可见ELISA结果良好,酶切回收的单体蛋白具有良好的反应原性,检测结果见表2:Dilute the recovered F protein and undigested F protein with pH9.6 0.5mol/L carbonate buffer solution to 10 μg/mL and coat a 96-well plate, and infect chicken positive serum and Negative sera were primary antibodies that were serially diluted in 3 gradients, 1:100, 1:300, and 1:500, respectively. HRP-labeled goat anti-chicken IgG was used as the secondary antibody, and the working concentration was 1:10000; two wells were prepared in parallel for each sample, and after color development by TMB, the OD 450nm value of each well was read, and the results showed that: without enterokinase digestion And the protein with the carrier tag is used as the antigen coated on the ELISA plate. When the serum is detected, the OD value of the negative serum is between 0.6-0.8, which is close to the OD value of the positive serum; after the enterokinase enzyme digestion treatment, only the monomer remains The protein is used as the coating antigen of the ELISA plate. When testing the serum, the negative OD value is between 0.1-0.2, and the P/N value between the positive OD value and the negative OD value is between 3.6-4.45. It can be seen that the ELISA result is good, and the enzyme digestion recovery The monomeric protein has good reactogenicity, and the test results are shown in Table 2:
表2ELISA检测KCl染色法切胶纯化蛋白的抗原性Table 2 ELISA detection of antigenicity of KCl staining gel cutting purified protein
实施例3禽偏肺病毒ELISA检测方法的建立The establishment of embodiment 3 avian metapneumovirus ELISA detection method
1.A亚群禽偏肺病毒抗体ELISA检测试剂盒最佳反应条件的确定1. Determination of the optimal reaction conditions of ELISA detection kit for subgroup A avian metapneumovirus antibody
1)抗原最佳包被浓度和酶标单抗最佳工作浓度的确定1) Determination of the optimal coating concentration of the antigen and the optimal working concentration of the enzyme-labeled monoclonal antibody
以纯化的F单体蛋白为包被抗原,HRP标记的羊抗鸡单抗为第二抗体,在酶标板上进行方阵滴定试验。用碳酸盐缓冲液将酶切回收的F蛋白分别作15μg/ml、10μg/mL、5μg/mL、2.5μg/mL,稀释4个稀释度,每个稀释度重复2孔,100μL/孔,4℃包被酶标板过夜。将鸡的阴性和阳性血清分别作1:100、1:300、1:500倍比稀释,每个稀释度重复2孔,100μL/孔,组成方阵确定重组蛋白的最佳包被浓度和一抗稀释比列。封闭1h后,每个稀释度重复2孔,100μL/孔,各步37℃反应30min,37℃显色5min后终止,在酶标仪测定各孔OD450nm值。由表3可以看出,抗原包被量为1000ng/孔,血清稀释浓度为1:100时视为效果最佳,(经计算,当蛋白包被浓度为1000ng/孔、血清稀释度为1:100时,OD450nm测得吸光度P/N值最大)The purified F monomeric protein was used as the coating antigen, and the HRP-labeled goat anti-chicken monoclonal antibody was used as the second antibody, and the square array titration test was carried out on the enzyme plate. Dilute the F protein recovered by enzyme digestion with carbonate buffer to 15 μg/ml, 10 μg/mL, 5 μg/mL, 2.5 μg/mL, respectively, and dilute 4 dilutions, each dilution is repeated for 2 wells, 100 μL/well, Coat the plate overnight at 4°C. The negative and positive sera of the chicken were diluted 1:100, 1:300, 1:500 respectively, and each dilution was repeated for 2 wells, 100 μL/well, to form a square matrix to determine the optimal coating concentration of the recombinant protein and a Antidilution ratio column. After blocking for 1 hour, repeat 2 wells for each dilution, 100 μL/well, react at 37°C for 30 minutes in each step, stop after 5 minutes of color development at 37°C, and measure the OD 450nm value of each well with a microplate reader. As can be seen from Table 3, the antigen coating amount is 1000ng/well, and the effect is considered to be the best when the serum dilution concentration is 1:100. At 100, the absorbance P/N value measured at OD 450nm is the largest)
表3抗原包被浓度和血清稀释度的确定Table 3 Determination of antigen coating concentration and serum dilution
2)最佳包被条件的选择2) Selection of the best coating conditions
以最佳抗原包被浓度包被酶标板,每个包被浓度重复2孔,分别以4°C过夜、37°C作用1h后再4°C过夜包被,测定各孔OD450nm值,计算P/N值选择最佳包被条件。从表4中可以看出,37°C1h后4°C过夜为最佳包被条件。Coat the ELISA plate with the optimal antigen coating concentration, repeat 2 wells for each coating concentration, treat at 4°C overnight, 37°C for 1 hour, and then coat at 4°C overnight, measure the OD 450nm value of each well, Calculate the P/N value to select the best coating condition. As can be seen from Table 4, overnight at 4°C after 1h at 37°C is the best coating condition.
表4包被条件的选择Table 4 Selection of Coating Conditions
3)封闭液和封闭时间的选择3) Selection of blocking solution and blocking time
以最适抗原包被浓度包被酶标板,以最佳包被条件包被抗原,分别以下列三种封闭液进行试验:5%脱脂奶、5%小牛血清、1%BSA,每个封闭液重复2孔;分别以下列3个条件封闭,进行试验:37°C30min、37°C1h、37°C1.5h、37°C2h,每个封闭条件重复2孔。测各孔OD450值,计算P/N值。从表5中可以看出,2h5%脱脂奶为最佳条件。Coat the ELISA plate with the optimal antigen coating concentration, and coat the antigen with the optimal coating condition, and conduct the test with the following three blocking solutions: 5% skimmed milk, 5% calf serum, 1% BSA, each Repeat the blocking solution for 2 wells; respectively seal with the following 3 conditions for testing: 37°C for 30min, 37°C for 1h, 37°C for 1.5h, and 37°C for 2h, repeat 2 wells for each blocking condition. Measure the OD 450 value of each well and calculate the P/N value. As can be seen from Table 5, 2h5% skimmed milk is the best condition.
表5封闭条件的确定Table 5 Determination of closing conditions
4)二抗最佳稀释度和反应时间的选择4) Selection of the optimal dilution and reaction time of the secondary antibody
以最佳包被条件,按最适抗原包被浓度包被酶标板,使用最佳封闭液在最佳封闭条件下封闭酶标板,二抗分别按1:10000、1:20000、1:30000、1:40000、1:50000稀释,37°C下作用时间分别为30min、1h、1.5h和2h,每个二抗条件重复2孔,测得各孔OD450nm值,计算P/N值。从表6可以看出,1:4000030min为最佳二抗作用浓度和时间。Coat the microtiter plate with the optimum coating condition and the optimum antigen coating concentration, use the optimum blocking solution to block the microtiter plate under the optimum blocking condition, and use the secondary antibodies at 1:10000, 1:20000, and 1:20000 respectively. 30000, 1:40000, 1:50000 dilution, the action time at 37°C is 30min, 1h, 1.5h and 2h respectively, each secondary antibody condition is repeated for 2 wells, the OD 450nm value of each well is measured, and the P/N value is calculated . It can be seen from Table 6 that 1:4000030min is the optimal concentration and time of secondary antibody action.
表6二抗浓度和二抗作用时间的选择Table 6 Selection of secondary antibody concentration and secondary antibody action time
5)底物显色时间的选择5) Selection of substrate color development time
以最佳包被条件,按最适抗原包被浓度包被酶标板,在最佳封闭液和封闭条件下,分别在室温显色10min、15min、20min、25min。测得各孔OD450nm值,计算P/N值,根据表7可以看出,显色时间为15min时P/N值较大,且阳性值在1.0左右,阴性值在0.1左右,为最佳条件,故选择显色15min为最佳底物显色时间。Coat the microtiter plate with the optimal coating conditions and the optimal antigen coating concentration, and develop color at room temperature for 10 min, 15 min, 20 min, and 25 min under the optimal blocking solution and blocking conditions, respectively. Measure the OD 450nm value of each well and calculate the P/N value. According to Table 7, it can be seen that the P/N value is larger when the color development time is 15 minutes, and the positive value is about 1.0, and the negative value is about 0.1, which is the best. Conditions, so 15 minutes for color development was selected as the best substrate color development time.
表7底物显色时间的确定Determination of the color development time of the substrate in table 7
6)Cut-off值的确定6) Determination of Cut-off value
选择阴性鸡血清20份,在最适抗原包被浓度和血清稀释度下,在以上确定的最佳反应条件下进行ELISA反应,结果如表8所示:Select 20 parts of negative chicken serum, under the optimal antigen coating concentration and serum dilution, carry out ELISA reaction under the optimal reaction condition determined above, the result is as shown in table 8:
表820份阴性鸡血清的测定结果The assay result of table 820 negative chicken sera
20份血清的平均值X=0.1639,标准差SD=0.026052,根据公式,阳性的cut-off值为0.2419(Cp=X+3SD)、阴性的cut-off值为0.2159(Cn=X+2SD)。用公式S/P=(S-N)/(P-N)来判定结果,若S/P≥Cp,待检血清为阳性;若S/P<Cn,待检血清为阴性;若Cp>S/P≥Cn,判为可疑,需重新测定。(S代表待检样品的OD450值;P代表阳性对照的OD450值;N代表阴性对照的OD450值)。The mean value X=0.1639 of 20 sera, standard deviation SD=0.026052, according to the formula, the positive cut-off value is 0.2419 (Cp=X+3SD), the negative cut-off value is 0.2159 (Cn=X+2SD) . Use the formula S/P=(SN)/(PN) to judge the result. If S/P≥Cp, the serum to be tested is positive; if S/P<Cn, the serum to be tested is negative; if Cp>S/P≥ Cn is judged as suspicious and needs to be re-measured. (S represents the OD450 value of the sample to be tested; P represents the OD450 value of the positive control; N represents the OD450 value of the negative control).
7)板间重复性实验7) Inter-plate repeatability experiment
取4块不同批次包被的酶标板,检测已知阳性血清4份,每个样品每块板设置2个重复,计算批间变异系数CV=(SD/OD450nm平均值)×100%,结果见表9:Take 4 coated ELISA plates from different batches, detect 4 copies of known positive sera, set 2 replicates per plate for each sample, and calculate the inter-assay coefficient of variation CV=(SD/OD450nm average value)×100%, The results are shown in Table 9:
表9批间变异系数的确定Determination of coefficient of variation between batches of table 9
OD450nm平均值=0.963969,SD=0.07474,根据公式计算计算批间变异系数CV=(SD/OD450nm平均值)×100%=7.75%,CV<10%,说明同一血清样本在不同板间的变异程度很小,具有很好的稳定性。The average value of OD450nm=0.963969, SD=0.07474, and the coefficient of variation between batches was calculated according to the formula CV=(SD/OD450nm average value)×100%=7.75%, CV<10%, indicating the degree of variation of the same serum sample among different plates Small and has great stability.
8)板内重复性实验8) In-plate repeatability experiment
在同一块酶标板上进行批内重复,检测已知阳性血清4份,每个样品设置4个重复,计算批内变异系数CV=(SD/OD450nm平均值)×100%,结果见表10:Intra-batch repetitions were carried out on the same ELISA plate, 4 copies of known positive sera were detected, 4 replicates were set for each sample, and the intra-assay coefficient of variation CV=(SD/OD450nm average value)×100% was calculated. The results are shown in Table 10 :
表10批内变异系数的确定Determination of coefficient of variation within table 10 batches
OD450nm平均值=0.975313,SD=0.072513,根据公式计算计算批间变异系数CV=(SD/OD450nm平均值)×100%=7.43%,CV<10%,说明不同血清样本在同一板内的变异程度很小,具有很好的重复性。The average value of OD450nm=0.975313, SD=0.072513, according to the formula to calculate the coefficient of variation between batches CV=(SD/OD450nm average value)×100%=7.43%, CV<10%, indicating the degree of variation of different serum samples in the same plate Small and very repeatable.
9)间接ELISA方法的特异性实验9) Specificity experiment of indirect ELISA method
利用建立的间接ELISA方法,检测阳性血清,对照组采用AEV/ND/REO/IBD/IB血清和阴性血清,阳性血清OD450nm接近1.0,阴性血清OD450nm在0.1-0.2,对照组血清OD450nm在0.1-0.2,证明用该蛋白建立的间接ELISA方法特异性较好,结果见表11:Using the established indirect ELISA method to detect positive serum, the control group uses AEV/ND/REO/IBD/IB serum and negative serum, the positive serum OD 450nm is close to 1.0, the negative serum OD 450nm is at 0.1-0.2, and the control group serum OD 450nm is at 0.1-0.2, it proves that the specificity of the indirect ELISA method established with this protein is better, the results are shown in Table 11:
表11间接ELISA方法的特异性The specificity of table 11 indirect ELISA method
10)间接ELISA方法的敏感性实验10) Sensitivity experiment of indirect ELISA method
将一抗血清按1:200、1:400、1:600、1:800、1:1000的比例进行稀释,以确定其敏感性。数据结果显示在稀释比例达到1:1000时仍能检测出阳性,证明此方法的敏感性很好,结果见表12:The primary antiserum was diluted at ratios of 1:200, 1:400, 1:600, 1:800, and 1:1000 to determine its sensitivity. The results of the data show that positive results can still be detected when the dilution ratio reaches 1:1000, which proves that the sensitivity of this method is very good. The results are shown in Table 12:
表12间接ELISA方法的敏感性Table 12 Sensitivity of indirect ELISA method
11)间接ELISA方法的比较实验11) Comparative experiment of indirect ELISA method
用建立的ELISA方法与美国IDEXX公司aMPV抗体检测试剂盒(ELISA)对164份临床送检血清进行平行检测,结果显示,二者的阳性符合率为96.77%(120/124),阴性符合率为92.5%(37/40),总符合率达到95.73%(157/164),结果见表13至表16,结果表明建立的间接ELISA方法具有较高的特异性和敏感性。Using the established ELISA method and the American IDEXX company aMPV antibody detection kit (ELISA) to conduct parallel detection on 164 clinically submitted sera, the results showed that the positive coincidence rate of the two was 96.77% (120/124), and the negative coincidence rate was 96.77%. 92.5% (37/40), the total coincidence rate reached 95.73% (157/164), the results are shown in Table 13 to Table 16, the results show that the established indirect ELISA method has high specificity and sensitivity.
表13广西南宁采样40份血清的ELISA检测结果Table 13 ELISA detection results of 40 samples of serum in Nanning, Guangxi
表14北京大兴46份鸡血清的ELISA检测结果Table 14 ELISA detection results of 46 chicken sera in Beijing Daxing
表15北京平谷40份血清的ELISA检测结果Table 15 ELISA detection results of 40 sera in Pinggu, Beijing
表16北京海淀38份血清的ELISA检测结果Table 16 ELISA detection results of 38 sera in Haidian, Beijing
实施例4禽偏肺病毒抗体ELISA检测试剂盒的组装The assembly of embodiment 4 avian metapneumovirus antibody ELISA detection kit
1.ELISA试剂盒组装1. ELISA kit assembly
⑴96孔酶标板:包被有F蛋白的单体蛋白;(1) 96-well ELISA plate: monomeric protein coated with F protein;
⑵标准阳性对照:感染禽偏肺病毒鸭阳性血清;(2) Standard positive control: Positive serum of ducks infected with avian metapneumovirus;
⑶标准阴性对照:一份正常健康鸭血清;(3) Standard negative control: a normal healthy duck serum;
⑷辣根过氧化物酶标记的羊抗鸡单克隆抗体;(4) horseradish peroxidase-labeled goat anti-chicken monoclonal antibody;
⑸包被液:无水Na2CO31.59g,NaHCO32.93g,加蒸馏水至1000ml;(5) Coating solution: anhydrous Na 2 CO 3 1.59g, NaHCO 3 2.93g, add distilled water to 1000ml;
⑹洗涤液:NaCl8.0g,KH2PO40.2g,Na2HPO4·12H2O2.9g,KCl0.2g,Tween200.5mL,加双蒸水至1000mL;(6) Washing liquid: NaCl8.0g, KH2PO40.2g , Na2HPO4 · 12H2O2.9g , KCl0.2g , Tween200.5mL, add double distilled water to 1000mL ;
(7)底物液A:过氧化脲1.0g,Na2HPO4·12H2O35.8g,柠檬酸·H2O10.3g,Tween-20100μL,加1000mL蒸馏水;(7) Substrate solution A: carbamide peroxide 1.0g, Na 2 HPO 4 12H 2 O 35.8g, citric acid H 2 O 10.3g, Tween-20 100μL, add 1000mL distilled water;
(8)底物液B:TMB700mg,DMSO40mL,充分溶解,然后加蒸馏水960mL,柠檬酸·H2O10.3g;(8) Substrate solution B: TMB700mg, DMSO40mL, fully dissolved, then add distilled water 960mL, citric acid H 2 O10.3g;
(9)封闭液:5%脱脂奶粉;(9) Blocking solution: 5% skimmed milk powder;
(10)稀释液:含5%脱脂奶粉的洗涤液;⑼终止液:2mol/L硫酸溶液。(10) Diluent: Washing solution containing 5% skimmed milk powder; ⑼Terminator solution: 2mol/L sulfuric acid solution.
2.酶标板的制备2. Preparation of ELISA plate
用碳酸盐(pH9.6,浓度0.5mol/L)缓冲液作包被液,用上述包被液将F蛋白单体稀释为10μg/mL,按100μL/孔加入ELISA反应板中,37°C封闭1小时,4°C包被过夜,拍干,再用5%脱脂奶37°C封闭2小时,以含0.05%吐温的PBST洗涤,拍干用铝膜真空封闭保存、备用。Use carbonate (pH9.6, concentration 0.5mol/L) buffer as the coating solution, dilute the F protein monomer to 10μg/mL with the above coating solution, add 100μL/well into the ELISA reaction plate, and keep at 37° C to block for 1 hour, 4°C to coat overnight, pat dry, then block with 5% skimmed milk at 37°C for 2 hours, wash with PBST containing 0.05% Tween, pat dry and store in vacuum with aluminum film for future use.
实施例5A亚型禽偏肺病毒抗体ELISA检测试剂盒的测定程序The assay procedure of embodiment 5A subtype avian metapneumovirus antibody ELISA detection kit
1.试剂配制及样品稀释1. Reagent preparation and sample dilution
1)本发明试剂盒内试剂无需配制,可直接使用;1) The reagents in the kit of the present invention do not need to be prepared and can be used directly;
2)待检样品及标准对照品的稀释:将待检测血清样品及试剂盒中提供的标准阳性、标准阴性对照品用样品稀释液稀释10倍后使用。2) Dilution of samples to be tested and standard control substances: Dilute the serum samples to be tested and the standard positive and standard negative control substances provided in the kit by 10 times with the sample diluent before use.
2.测定步骤2. Measurement steps
1)加样:向酶标板微孔中加入用样品稀释液1:100倍稀释后的待检测血清样品100μL,37°C恒温孵育60min;1) Adding samples: Add 100 μL of the serum sample to be tested diluted 1:100 times with the sample diluent to the microwell of the microplate, and incubate at 37°C for 60 minutes;
2)洗涤:倒出孔中的液体,每孔中加入洗涤液250μL,洗涤3次并拍干;2) Washing: Pour out the liquid in the wells, add 250 μL of washing solution to each well, wash 3 times and pat dry;
3)加酶标抗体:每孔中加入酶标抗体工作液100μL,37°C恒温孵育60min;3) Add enzyme-labeled antibody: add 100 μL of enzyme-labeled antibody working solution to each well, and incubate at 37°C for 60 minutes;
4)洗涤:倒出孔中的液体,每孔中加入洗涤液250μL,洗涤3次并拍干;4) Washing: Pour out the liquid in the wells, add 250 μL of washing solution to each well, wash 3 times and pat dry;
5)加底物液:每孔中先加入底物液A50μL,再加入底物液B50μL,避光显色15min;5) Add substrate solution: first add 50 μL of substrate solution A to each well, then add 50 μL of substrate solution B, and develop color in the dark for 15 minutes;
6)加终止液:每孔中加入终止液50μL;6) Add stop solution: add 50 μL of stop solution to each well;
7)测定:用酶标仪在OD450nm处测定每孔的吸光光度值(OD450nm值)。7) Determination: Use a microplate reader to measure the absorbance value (OD 450nm value) of each well at OD 450nm .
3.结果判断3. Result judgment
计算其吸光度值的平均数(X)和标准差(SD),则阳性的Cut-off值Cp=X+3SD;阴性的Cut-off值Cn=X+2SD。运用公式S/P=(S–N)/(P–N)来判定结果(S:待检样品的OD450nm值;P:阳性对照的OD450nm值;N:阴性对照的OD450nm值)。若S/P≥Cp,待检血清为阳性;若S/P<Cn,待检血清为阴性;若Cp>S/P≥Cn,判为可疑,需重新测定。(S代表待检样品的OD450nm值;P代表阳性对照的OD450nm值;N代表阴性对照的OD450nm值)。Calculate the mean (X) and standard deviation (SD) of the absorbance values, then the positive Cut-off value Cp=X+3SD; the negative Cut-off value Cn=X+2SD. Use the formula S/P=(S–N)/(P–N) to determine the result (S: OD 450nm value of the sample to be tested; P: OD 450nm value of the positive control; N: OD 450nm value of the negative control). If S/P≥Cp, the serum to be tested is positive; if S/P<Cn, the serum to be tested is negative; if Cp>S/P≥Cn, it is suspicious and needs to be re-tested. (S represents the OD 450nm value of the sample to be tested; P represents the OD 450nm value of the positive control; N represents the OD 450nm value of the negative control).
Claims (10)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310325109.8A CN103360472B (en) | 2013-07-30 | 2013-07-30 | Acian Metapneumovirus antibody ELISA detection kit |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310325109.8A CN103360472B (en) | 2013-07-30 | 2013-07-30 | Acian Metapneumovirus antibody ELISA detection kit |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103360472A CN103360472A (en) | 2013-10-23 |
| CN103360472B true CN103360472B (en) | 2015-02-25 |
Family
ID=49362803
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310325109.8A Expired - Fee Related CN103360472B (en) | 2013-07-30 | 2013-07-30 | Acian Metapneumovirus antibody ELISA detection kit |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103360472B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104911153B (en) * | 2015-07-10 | 2018-02-27 | 青岛易邦生物工程有限公司 | A kind of method for separating fowl metapneumovirus |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105296439B (en) * | 2015-09-08 | 2019-01-04 | 北京市农林科学院 | One breeder c-type fowl metapneumovirus strain aMPV/C-JCX and its application |
| CN105296440B (en) * | 2015-09-08 | 2019-01-04 | 北京市农林科学院 | One breeder c-type fowl metapneumovirus strain aMPV/C-JCZ and its application |
| CN106546732A (en) * | 2015-09-17 | 2017-03-29 | 深圳迈瑞生物医疗电子股份有限公司 | Human immunodeficiency virus antigen and antibody combined detection kit and application thereof and detection method |
| CN105177183B (en) * | 2015-09-18 | 2018-10-16 | 中国农业科学院哈尔滨兽医研究所 | The method for detecting the RT-PCR of fowl metapneumovirus |
| CN105693829B (en) * | 2016-04-14 | 2022-03-15 | 青岛易邦生物工程有限公司 | B-type avian metapneumovirus F protein |
| CN107904326B (en) * | 2017-12-12 | 2021-06-22 | 北京市农林科学院 | Nucleic acid for RT-PCR rapid typing detection of avian metapneumovirus subtype and application |
| CN109001450A (en) * | 2018-04-24 | 2018-12-14 | 中国农业科学院兰州兽医研究所 | A kind of kit and preparation method detecting chicken Mycoplasma synoviae antibody |
| CN110596400B (en) * | 2019-09-02 | 2023-04-07 | 佛山市正典生物技术有限公司 | Indirect ELISA detection method based on recombinant R7 protein of Kashi leucocytozoon and application thereof |
| CN112881682A (en) * | 2021-01-11 | 2021-06-01 | 广西大学 | Indirect ELISA (enzyme-linked immunosorbent assay) detection kit for avian metapneumovirus antibody |
| CN115466317A (en) * | 2022-06-16 | 2022-12-13 | 广西大学 | Polyclonal antibody prepared based on PEDV ORF3 recombinant protein and established indirect ELISA detection method |
| CN119355265B (en) * | 2024-12-25 | 2025-04-11 | 北京万泰生物药业股份有限公司 | Preparation method and application of high-flux FAMA virus plate |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101921732A (en) * | 2001-01-19 | 2010-12-22 | 维洛诺瓦蒂夫公司 | A virus causing respiratory tract illness in susceptible mammals |
-
2013
- 2013-07-30 CN CN201310325109.8A patent/CN103360472B/en not_active Expired - Fee Related
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104911153B (en) * | 2015-07-10 | 2018-02-27 | 青岛易邦生物工程有限公司 | A kind of method for separating fowl metapneumovirus |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103360472A (en) | 2013-10-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103360472B (en) | Acian Metapneumovirus antibody ELISA detection kit | |
| CN104007261B (en) | Triple Rapid Detection Kit and Application of Three Poultry Respiratory Diseases | |
| CN106596933B (en) | Newcastle disease virus antibody test blocks ELISA kit | |
| CN102675469A (en) | Novel duck reovirus recombinant sigma B protein antigen, preparation method and application | |
| CN107607717A (en) | The indirect ELISA reagent kit of the detection type aviadenovirus antibody of serum 4 based on F2 albumen | |
| CN112574319A (en) | African swine fever virus P12 protein nanoparticle and preparation method and application thereof | |
| CN106442981B (en) | A kind of 1 type antibody indirect ELISA diagnostic kit of human bocavirus | |
| CN112574318A (en) | African swine fever virus P22 protein nanoparticle and preparation method and application thereof | |
| CN108715857A (en) | A kind of bovine coronavirus VPN genes, the recombinant protein of coding and application | |
| CN106443015A (en) | ELISA (Enzyme Linked Immunosorbent Assay) kit for detecting fowl adenovirus antibody based on hexon protein N-terminal conservative area | |
| CN104262484A (en) | Specific IgY antibody for resisting African swine fever virus as well as preparation method and application thereof | |
| CN115746130A (en) | Duck reovirus monoclonal antibody NDRV-sigma C and detection kit and application thereof | |
| Zhang et al. | Development of an indirect ELISA with artificially synthesized N protein of PPR virus | |
| CN112505330B (en) | Kit for detecting novel coronavirus based on fusion protein of nucleocapsid protein | |
| CN118112239A (en) | ELISA detection kit and method for lawsonia intracellularis antibody | |
| CN103933560B (en) | Preparation method of chimeric vaccine by using Ii-Key active tetrapeptide carrying Fabricius bursa VP2 and newcastle disease HN antigen peptide epitope | |
| CN105092839A (en) | Detection kit for chicken infectious bronchitis indirect ELISA antibody | |
| CN103275194A (en) | Antigen of pig transmissible gastroenteritis virus or pig respiratory tract coronavirus antibody in pig serum and enzyme-linked immunosorbent assay (ELISA) detection method thereof | |
| CN110483625A (en) | A kind of Mycoplasma bovis imagination albumen MbovP732 and its application | |
| Li et al. | Mapping B-cell linear epitopes of NS3 protein of bovine viral diarrhea virus | |
| CN102618557B (en) | Recombinant avian flavivirus E protein and application thereof | |
| CN102590503A (en) | Indirect blocking ELISA (Enzyme-Linked Immuno Sorbent Assay) detection kit of antibody of porcine torque teno virus type II | |
| CN110161246B (en) | Indirect competitive ELISA method and kit for distinguishing Newcastle disease virus-like particle vaccine immune serum and wild virus infection serum | |
| CN102174091B (en) | Truncated and expressed duck plague virus (DPV) recombinant envelope gI protein and preparation method and application thereof | |
| CN110568189B (en) | Dog adenovirus type 1 antibody ELISA detection kit and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150225 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |